Mike Patten

CSO at Harbour BioMed

Speaker

Mike Patten is Chief Strategy Officer of Harbour BioMed, a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immunology and oncology. Mike is responsible for formulating and overseeing the global growth and business development strategies for Harbour BioMed. He leads efforts to manage and strengthen Harbour BioMed’s global strategic partner network and ecosystem, with a particular focus on high-potential markets outside of China, further enhancing Harbour BioMed’s global presence.

Mike brings extensive experience and a strong track record in the biopharmaceutical industry. During his tenure at Bristol Myers Squibb, he held several key leadership roles. Most recently, as Head of Equity & Venture Capital, he led and managed several strategic equity investments and LP commitments across the life science ecosystem. Prior, he held roles of increasing seniority in Business Development and Alliance Leadership, successfully executing transactions and managing multiple early- and late-stage business development alliances. In addition, Mike is a board and corporate strategy advisor to several early stage biotechs globally.